posted 01/09/03
Researchers discover that a blood-borne molecule known to make
human serum also makes fat cells.
The discovery was made recently by University of
Utah researchers in conjunction with Japanese chemists. It holds promise for
improved drug treatments in Type 2 diabetes patients and increasing the
understanding of heart disease in its earliest clinical stages, they say.
In the study, researchers discovered that LPA,
short for lysophosphaditic acid, activates a nuclear hormone receptor called
PPARgamma to make fat cells and sensitize the body to insulin. Previously, LPA
had been known as a major growth factor for human serum, the clear liquid that
can be separated from clotted blood, said U. professor of internal medicine
Thomas McIntyre, who also is one of the study's authors.
"One million or more Type 2 diabetics take
medications every day that mimic LPA's function in activating PPARgamma,"
McIntyre said in a statement. "Now that LPA's role in turning on the receptor is
known, researchers may have an avenue to develop new drugs for Type 2
diabetics."
The researchers also discovered, based on this
new information, that LPA changes blood vessels and plays a role in the buildup
of fat, cholesterol and other substances likely to clog arteries. The U. and
University of Tokyo study is published in a recent issue of Proceedings of the
National Academy of Sciences.
McIntyre said in his statement that biological
mechanisms in diabetes and atherosclerosis are related, and that this discovery
raises questions about whether genes involved in the development of diabetes are
related to LPA in the blood.
One year ago this month, researchers working
independently at two separate laboratories discovered PPARgamma's role in
fat-cell development. The two teams found the gene that encodes the PPARgamma
protein is responsible for fat-cell development, or adipogenesis. PPARgamma is a
nuclear hormone receptor that regulates gene expression in response to
extra-cellular signals.
The determination LPA and PPARgamma interact to
make fat cells provides an attractive molecular target for future drug design,
the U. study says.
Source: Diabetes In Control Dot Com.
January 2003 News Article Index
Home - Table of Contents - Donate Now - About Diabetes - Warning Signs - Complications - Screening Test - Diabetes Terms - Site Search - Meet Mr. Diabetes® - Wake Up And Walk® Tour - Latest News - Headlines & News Stories - Health & Fitness - About Us - FAQ - Research Form - - Message Board - Privacy Policy - Legal Notices - How to Contact Us - Comments form - Suggestion Form - Our E-Mail Addresses - Our Address and Phone Numbers - Links - Contact Us